Advertisement
Advertisement

TNXP

TNXP logo

Tonix Pharmaceuticals Holding Corp.

12.66
USD
Sponsored
-0.37
-2.80%
Jul 10, 15:41 UTC -4
Open

TNXP Earnings Reports

Positive Surprise Ratio

TNXP beat 21 of 42 last estimates.

50%

Next Report

Date of Next Report
Aug 10, 2026
Estimate for Q2 26 (Revenue/ EPS)
$7.88M
/
-$2.75
Implied change from Q1 26 (Revenue/ EPS)
+14.52%
/
-6.14%
Implied change from Q2 25 (Revenue/ EPS)
+294.24%
/
-28.76%

Tonix Pharmaceuticals Holding Corp. earnings per share and revenue

On May 11, 2026, TNXP reported earnings of -2.93 USD per share (EPS) for Q1 26, missing the estimate of -2.48 USD, resulting in a -18.05% surprise. Revenue reached 6.88 million, compared to an expected 6.25 million, with a 10.09% difference. The market reacted with a -5.88% price change (close before vs. close after earnings).
Looking ahead to Q2 26, 3 analysts forecast an EPS of -2.75 USD, with revenue projected to reach 7.88 million USD, implying an decrease of -6.14% EPS, and increase of 14.52% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Cybin Inc. Common Stock
Report Date
Jun 29, 2026 For Q4 26
Estimate
-$0.91
Actual
-$1.16
Surprise
-27.08%
FAQ
For Q1 2026, Tonix Pharmaceuticals Holding Corp. reported EPS of -$2.93, missing estimates by -18.05%, and revenue of $6.88M, 10.09% above expectations.
The stock price moved down -5.88%, changed from $14.11 before the earnings release to $13.28 the day after.
The next earning report is scheduled for Aug 10, 2026.
Based on 3 analysts, Tonix Pharmaceuticals Holding Corp. is expected to report EPS of -$2.75 and revenue of $7.88M for Q2 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement